Buy Perjeta (Pertuzumab)
$1,470.00
Perjeta (pertuzumab) is a medication used for the treatment of HER2 positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory, or early stage breast cancer as part of a complete treatment regimen for early breast cancer.
What is Perjeta (pertuzumab) for?
Perjeta (pertuzumab) is indicated for the treatment of HER2 positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory, or early stage breast cancer as part of a complete treatment regimen for early breast cancer
Description
How does Perjeta (pertuzumab) work?
Perjeta (pertuzumab) is used in combination with trastuzumab and docetaxel (other cancer medicines) for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
It is also used in combination with trastuzumab and chemotherapy as neoadjuvant treatment for patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer as part of a complete treatment regimen for early breast cancer.
Is Perjeta (pertuzumab) approved?
Perjeta (pertuzumab) was approved for HER2 positive breast cancer in metastatic patients or as neoadjuvant therapy by:
- FDA (USA) on June 12, 2012
- EMA (EU) on March 4, 2013
- TGA (AUS) on May 6, 2013
- Health Canada on May 8, 2013
- Medsafe (New Zealand) on July 18, 2013
How do I take Perjeta (pertuzumab)?
The standard dosage is:
- Initial dose: 840 mg administered as a 60-minute intravenous infusion
- Following infusions: 420 mg administered as a 30 to 60-minute intravenous infusion every 3 weeks.
Patients with metastatic breast cancer should be treated with pertuzumab and trastuzumab until disease progression or unmanageable toxicity.
Patients in neoadjuvant treatment of breast cancer should be administered pertuzumab every 3 weeks for 3 to 6 cycles before surgery.
Complete information about Perjeta (pertuzumab) dosage and administration can be found in the references section.
Note: Consult your treating doctor for personalised dosing.
Common side effects of Perjeta (pertuzumab)
The most common side effects with Perjeta given with trastuzumab and chemotherapy are:
- diarrhoea
- alopecia (hair loss)
- nausea
- neutropenia (low levels of neutrophils, a type of white blood cell important for fighting infections).
Serious side effects of Perjeta (pertuzumab)
The most common serious side effects include:
- febrile neutropenia (low levels of neutrophils with fever)
- serious diarrhoea
- leucopenia (low white blood cell counts)
- neutropenia.
Additional information
| Package | 420 mg/14 mL |
|---|
1 review for Buy Perjeta (Pertuzumab)
Related Products
-
Buy Kadcyla (Trastuzumab Emtansine)
$1,665.90 – $2,669.40 Select options This product has multiple variants. The options may be chosen on the product page -
Buy Vegzelma (Bevacizumab-adcd)
$375.00 – $1,125.00 Select options This product has multiple variants. The options may be chosen on the product page -
Buy Keytruda (pembrolizumab)
$2,050.00 Select options This product has multiple variants. The options may be chosen on the product page
Emma Wilson –
Perjeta has been a true game-changer in my battle against HER2-positive breast cancer. This medication, in combination with other therapies, has provided a powerful defense against my aggressive cancer. Since starting Perjeta, my oncologist and I have observed significant reductions in tumor size, giving me newfound hope and confidence in my treatment plan. While I’ve experienced some manageable side effects like mild nausea and fatigue, they have been outweighed by the positive outcomes and improvements in my health. The convenience of receiving Perjeta alongside other treatments has simplified my regimen, allowing me to focus on healing and living my life to the fullest. I’m grateful for the advancements in medical science that have brought about medications like Perjeta, offering targeted and effective solutions for those facing challenging diagnoses like mine.